Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.
Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...
Caitlin Havener on MSN
Why I stopped doing high-intensity cardio for longevity
There's a moment most of us hit, usually somewhere in our late thirties or forties, when the workout we've been proudly ...
Kelowna Medical Aesthetics & Wellness Clinic (formerly Kelowna Medical Aesthetics) has a new name and has moved to a new ...
Veterans fighting the muscle disease known as IBM say they want the U.S. government to recognize their condition as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results